These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23138851)

  • 21. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function.
    Lei Q; Xiang K; Cheng L; Xiang M
    Stem Cell Reports; 2024 Jan; 19(1):68-83. PubMed ID: 38101398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of OPA1 on mitochondrial Ca²⁺ signaling.
    Fülöp L; Szanda G; Enyedi B; Várnai P; Spät A
    PLoS One; 2011; 6(9):e25199. PubMed ID: 21980395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network.
    Kamei S; Chen-Kuo-Chang M; Cazevieille C; Lenaers G; Olichon A; Bélenguer P; Roussignol G; Renard N; Eybalin M; Michelin A; Delettre C; Brabet P; Hamel CP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4288-94. PubMed ID: 16249510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Ca2+ signalling in postnatal mouse retinal ganglion cells: involvement of OPA1 in Ca2+ clearance.
    Dayanithi G; Chen-Kuo-Chang M; Viero C; Hamel C; Muller A; Lenaers G
    Ophthalmic Genet; 2010 Jun; 31(2):53-65. PubMed ID: 20450306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells.
    Ju WK; Kim KY; Lindsey JD; Angert M; Patel A; Scott RT; Liu Q; Crowston JG; Ellisman MH; Perkins GA; Weinreb RN
    Mol Vis; 2009; 15():120-34. PubMed ID: 19169378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseases.
    Wu W; Zhao D; Shah SZA; Zhang X; Lai M; Yang D; Wu X; Guan Z; Li J; Zhao H; Li W; Gao H; Zhou X; Qiao J; Yang L
    Cell Death Dis; 2019 Sep; 10(10):710. PubMed ID: 31551424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
    Davies VJ; Hollins AJ; Piechota MJ; Yip W; Davies JR; White KE; Nicols PP; Boulton ME; Votruba M
    Hum Mol Genet; 2007 Jun; 16(11):1307-18. PubMed ID: 17428816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Ca2+ uptake correlates with the severity of the symptoms in autosomal dominant optic atrophy.
    Fülöp L; Rajki A; Maka E; Molnár MJ; Spät A
    Cell Calcium; 2015 Jan; 57(1):49-55. PubMed ID: 25533789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations.
    Kao SH; Yen MY; Wang AG; Yeh YL; Lin AL
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2269-78. PubMed ID: 25744979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.
    Liao C; Ashley N; Diot A; Morten K; Phadwal K; Williams A; Fearnley I; Rosser L; Lowndes J; Fratter C; Ferguson DJ; Vay L; Quaghebeur G; Moroni I; Bianchi S; Lamperti C; Downes SM; Sitarz KS; Flannery PJ; Carver J; Dombi E; East D; Laura M; Reilly MM; Mortiboys H; Prevo R; Campanella M; Daniels MJ; Zeviani M; Yu-Wai-Man P; Simon AK; Votruba M; Poulton J
    Neurology; 2017 Jan; 88(2):131-142. PubMed ID: 27974645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
    Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
    Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OPA1 haploinsufficiency due to a novel splicing variant resulting in mitochondrial dysfunction without mitochondrial DNA depletion.
    Sun C; Wu X; Bai HX; Wang C; Liu Z; Yang C; Lu Y; Jiang P
    Ophthalmic Genet; 2021 Feb; 42(1):45-52. PubMed ID: 33251885
    [No Abstract]   [Full Text] [Related]  

  • 35. OPA1 functions in mitochondria and dysfunctions in optic nerve.
    Lenaers G; Reynier P; Elachouri G; Soukkarieh C; Olichon A; Belenguer P; Baricault L; Ducommun B; Hamel C; Delettre C
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1866-74. PubMed ID: 19389483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OPA1 expression in the normal rat retina and optic nerve.
    Ju WK; Misaka T; Kushnareva Y; Nakagomi S; Agarwal N; Kubo Y; Lipton SA; Bossy-Wetzel E
    J Comp Neurol; 2005 Jul; 488(1):1-10. PubMed ID: 15912498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function.
    Spinazzi M; Cazzola S; Bortolozzi M; Baracca A; Loro E; Casarin A; Solaini G; Sgarbi G; Casalena G; Cenacchi G; Malena A; Frezza C; Carrara F; Angelini C; Scorrano L; Salviati L; Vergani L
    Hum Mol Genet; 2008 Nov; 17(21):3291-302. PubMed ID: 18678599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina.
    Pesch UE; Fries JE; Bette S; Kalbacher H; Wissinger B; Alexander C; Kohler K
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4217-25. PubMed ID: 15505078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts.
    Cretin E; Lopes P; Vimont E; Tatsuta T; Langer T; Gazi A; Sachse M; Yu-Wai-Man P; Reynier P; Wai T
    EMBO Mol Med; 2021 Jun; 13(6):e13579. PubMed ID: 34014035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.